Satellite Symposia

To provide additional educational opportunities at AMCP Annual Meeting 2019, the Academy of Managed Care Pharmacy (AMCP) also allows non-commercial, grant-supported satellite symposia. These learning activities are developed by medical education organizations and are an important part of the meeting. Satellite symposia offer continuing pharmacy education (CPE) credit, and some offer continuing medical education (CME) credit and continuing nursing education (CNE) credit. All satellite symposia will be held at the San Diego Convention Center in San Diego, CA.

SS1: Managing Clinical and Cost Outcomes in Multiple Sclerosis: Expert Insights

Monday, March 25, 2019| 11:00 am – 1:00 pm

Jointly provided by Impact Education, LLC and Medical Education Resources, Inc.
Supported by independent educational grants from Celgene Corporation and Genzyme Corporation.
Continuing education credit available for pharmacists and physicians.

Program Description:
Despite the availability of more than a dozen disease modifying treatments (DMTs), health care resource utilization associated with multiple sclerosis (MS) is significant and continues to rise. The continually evolving MS treatment landscape accentuates the need for increased disease and therapeutic knowledge amongst managed care and specialty pharmacy professionals in order to optimize clinical outcomes, reduce treatment variability, and increase patient engagement in their own care. The expert faculty panel will discuss best practices to deliver quality care to MS patients and improve quality of life over the course of the disease.

Program Manager
Steven Casebeer, MBA
Impact Education, LLC
info@impactedu.net
215-619-8812, extension 102

No Fee Registration: Click Here

SS2: Headlights Through the Fog: How New Lipid Guidelines & Cardiovascular Evidence are Redefining Lipid Management

Monday, March 25, 2019 | 11:00 am – 1:00 pm

Provided by PRIME Education, LLC.
Supported by an independent educational grant from Sanofi US and Regeneron Pharmaceuticals.
Continuing education credit available for pharmacists, physicians and Nurses.

Program Description:
Newly-released guidelines and recently published cardiovascular outcomes data are transforming cholesterol management, especially for patients at high cardiovascular risk. Hear real-world patient perspectives and join leading lipidology and managed care experts as they debate the implications of new evidence and guidelines for better management of high-risk patients. This symposium will showcase new online tools, geared towards patients and providers, that are designed to improve the understanding of dyslipidemia management strategies and shared decision making. These innovative tools also feature the pharmacist-patient care process and a prior authorization section with an array of tips to assist care teams in communicating with insurers and specialty pharmacies.
Top 3 reasons to attend:
1. Hear real-world patient experiences in managing high cholesterol
2. Preview NEW online tools for cholesterol management
3. Ask the experts your most pressing questions about recently-released cholesterol guidelines and data

Program Manager
Tammy Gonzalez
PRIME Education, LLC
t.gonzalez@primeinc.org
954- 718-6055

No Fee Registration: Click Here

SS3: ManagedCareHemo.com Presents Hemophilia Clinical Updates and Cost Management Solutions

Monday, March 25, 2019 | 6:00 pm – 8:00 pm

Jointly provided by the National Hemophilia Foundation, Medical Education Resources, Inc., and Impact Education, LLC.
Supported by an independent educational grant from Shire, now part of Takeda.
Continuing education credit available for pharmacists and physicians.

Program Description:
The management of hemophilia is complex; however, appropriate management is vital to minimizing and/or preventing complications that can contribute to poorer health outcomes and higher health care resource utilization. The multidisciplinary faculty panel will emphasize the need for a well-coordinated patient management effort, the importance of understanding the most cost-effective ways of using available treatments, and the importance of collaboration among all stakeholders, which includes leveraging the success of the comprehensive care model utilized by hemophilia treatment centers (HTCs).

Program Manager
Steven Casebeer, MBA
Impact Education, LLC
info@impactedu.net
215-619-8812, extension 102

No Fee Registration: Click Here

SS4: Rheumatoid Arthritis with a Baby on Board? Exploring Treatment Options for Women of Childbearing Age

Tuesday, March 26, 2019 | 6:00 am – 8:00 am

Provided by PRIME Education, LLC.
Supported by an independent educational grant from UCB.
Continuing education credit available for pharmacists, physicians, and nurses.

Program Description:
Pregnant or lactating women with rheumatoid arthritis (RA) have historically been considered a difficult-to-treat population due to limited treatment options and unaddressed safety concerns. However, recent clinical trials and real-world data are shedding light on the safety and efficacy of disease-modifying antirheumatic drugs (DMARDs) for this unique patient population. What do these findings mean for managed care decision-making? Join this symposium to hear as a panel of renowned experts in RA, maternal fetal medicine, and managed care pharmacy untangle the evidence and address pressing questions faced by patients, providers, and payers in the setting of pregnancy.

Top 3 reasons to attend:

1. Learn what new evidence in RA treatment for women of childbearing age means for your organization
2. Engage in collaborative problem-solving to optimize RA decisions
3. Ask the experts your most pressing questions

Program Manager
Tammy Gonzalez
PRIME Education, LLC
t.gonzalez@primeinc.org
954-718-6055

No Fee Registration: Click Here

SS5: Today’s Concepts in EGFR TKIs for NSCLC

Tuesday, March 26, 2019 | 6:00 am – 8:00 am

Provided by Clinical Care Options, LLC.
Supported by an independent educational grant from AstraZeneca.
Continuing education credit available for pharmacists.

Program Description:
The therapeutic landscape for EGFR-mutated advanced or metastatic non-small-cell lung cancer (NSCLC) continues to evolve. With the availability of multiple EGFR TKIs, managed care pharmacy professionals need to be educated on how to best integrate these agents into care plans for their patients. In this interactive symposium, oncology and pharmacy expert panelists will provide their perspectives on the latest clinical evidence shaping optimal use of EGFR-targeted therapies in the management of advanced EGFR-mutated NSCLC. Topics will include: molecular testing; comparative efficacy of EGFR TKIs as related to the landscape of EGFR mutations; comparison of EGFR TKI toxicities and CNS activity; insights into the latest first-line and second-line clinical data on available EGFR TKIs; evaluation of a role for immunotherapy in the setting of acquired resistance to EGFR TKIs; future directions; and implementing clinical pathways in advanced EGFR-mutated NSCLC to deliver quality care. Attendees will have the opportunity to text in questions and case challenges to program faculty.

Program Manager
CCO Meetings
Clinical Care Options, LLC
Meetings@clinicaloptions.com

No Fee Registration: Click Here

SS6: An American Journal of Managed Care® Symposium: Managing Treatment Gaps with PCSK9 Inhibitors

Wednesday, March 27, 2019 | 6:00 am – 8:00 am

Provided by Pharmacy Times Continuing Education.
Supported by an independent educational grant from Amgen.
Continuing education credit available for pharmacists.

Program Description:
While statins have served as a mainstay of therapy for cholesterol management, patients frequently discontinue therapy or are unable to meet treatment goals, which underscores the importance of the development of PCSK9 inhibitors. This activity features a panel that includes a moderator, a physician, a pharmacist, and a managed care expert, all of whom offer unique perspectives on how PCSK9 inhibitors fit into the current treatment landscape of hypercholesterolemia. The evolving role of these agents is of interest due to the implications of new cost-versus-benefit data that can factor into effectively creating processes to manage this patient population.

Program Manager
Nicole Grassano
Pharmacy Times Continuing Education
ngrassano@pharmacytimes.com
609-716-7777 Ex. 164

No Fee Registration: Coming Soon

SS7: A Virtual View—Moderate-to-Severe Atopic Dermatitis: Long-Term Treatment and Managed Care Issues

Wednesday, March 27, 2019 | 6:00 am – 8:00 am

Jointly provided by Med Learning Group and Ultimate Medical Academy/CCM.
Supported by an independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Continuing education credit available for pharmacists, physicians and nurses.

Program Description:
The management of atopic dermatitis requires a multidisciplinary approach, within which the pharmacist is an essential piece. While physicians generally manage care for patients with atopic dermatitis, pharmacists, nurses and dieticians provide support and patient education while facilitating frequent check-ins with patients to improve adherence to treatment. This program will provide pharmacists an update on recent pathophysiological findings that drive new therapeutic targets; review severity and diagnosis of AD; and discuss the clinical profiles of existing and emerging agents.

Program Manager
Ana Maria Albino
Med Learning Group
aalbino@medlearninggroup.com
201-679-2906

No Fee Registration: Coming Soon

SS8: The Immuno-Oncology Transformation: Implications for Managed Care

Wednesday, March 27, 2019 | 6:00 pm – 8:00 pm

Jointly provided by Impact Education, LLC and Postgraduate Institute for Medicine.
Supported by an independent educational grant from Bristol-Myers Squibb.
Continuing education credit available for pharmacists and physicians.

Program Description:
The recent emergence of immuno-oncology agents has demonstrated promise for further revolutionizing cancer care. True to their name, these drugs extend the concept of targeted cancer therapies by leveraging the ability of the body’s immune system to effectively respond to oncogenic processes. The historically high cost of these agents has compelled payers to initiate strategies to control utilization and manage costs. This symposium will provide health care decision makers and managed care professionals with the required education on the principles of immuno-oncology and the mechanisms of action behind these novel treatments.

Program Manager
Steven Casebeer, MBA
Impact Education, LLC
info@impactedu.net
215-619-8812, extension 102

No Fee Registration: Click Here

SS9: Crossfire Debates on Patient Selection for New Asthma Therapies

Wednesday, March 27, 2019 | 6:00 pm – 8:00 pm

Provided by PRIME Education, LLC.
Supported by an independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Continuing education credit available for pharmacists, physicians, and nurses.

Program Description:
New targeted therapies for moderate-to-severe asthma span a range of therapeutic mechanisms, modes of administration, and approved indications. How can managed care organizations harness these therapies to meet patients' needs while balancing costs? Join leading asthma and managed care experts as they interpret the latest evidence and tackle some of the toughest questions in asthma patient selection and medication management.
Be a part of the discussion and connect with the expert faculty using real-time engagement technology. Each attendee will receive a tablet for the duration of the program, so register early to save your spot!

Top 3 reasons to attend:
1. Get hot-off-the-press evidence from major conferences, including the AMCP Annual Meeting 2019
2. Hear expert views on applications of cutting-edge research in the treatment of moderate-to-severe asthma
3. Exercise your problem-solving skills in decision-making for complex patients with asthma and comorbidities

Program Manager
Tammy Gonzalez
PRIME Education, LLC
t.gonzalez@primeinc.org
954-718-6055

No Fee Registration: Click Here

SS10: PARP Inhibitors in Cancer Therapy: A Managed Care Perspective in an Emerging Paradigm

Thursday, March 28, 2019 | 6:00 am – 7:45 am

Provided by Creative Educational Concepts/CEC Oncology.
Supported by an independent educational grant from AstraZeneca.
Continuing educational credit available for pharmacists and physicians.

Program Description:
The recent emergence of PARP inhibitors has helped renovate the treatment paradigm for a number of cancer types, including ovarian and breast, for which several of these agents have already been FDA approved, and clinical trial data continues to burgeon regarding the utility of PARP inhibition in prostate and pancreatic cancers as well. However, despite demonstrating formidable efficacy outcomes, especially in BRCA-mutated cells, clinicians still face a number of important challenges when integrating PARP inhibitors into practice. This program will explore innovative strategies that managed care and specialty clinicians can use to predict and manage safety and efficacy profiles, promote better adherence, and optimize outcomes for their patients.

Program Manager
Ashley C. Lilly, MHA
Creative Educational Concepts
alilly@ceconcepts.com
859-260-1717

No Fee Registration: Click Here

SS11: Emerging Immunologic Therapies for Multiple Sclerosis: Impact on Managed Care & Specialty Pharmacy

Thursday, March 28, 2019 | 6:00 am – 7:45 am

Jointly provided by Letters & Sciences and Postgraduate Institute for Medicine.
Supported by an independent educational grant from EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany.
Continuing education credit available for pharmacists and nurses.

Program Description:
Recent advances in the field of immunology and the increasing recognition of inflammation are re-shaping the conceptualization of multiple sclerosis, with potential implications of new agents within the current landscape of treatment options.

This symposium will examine the crucial role of managed care pharmacists in MS disease management programs, especially as new immune-directed agents emerge, in the application of current evidence-based diagnoses, guideline data, and pharmacy-based managed care best practices in reducing the clinical and economic burdens related to this complex chronic disorder while optimizing patient outcomes.

Program Manager
Jamie Miller, MSc
Letters & Sciences
jmiller@letsci.org
973 560-1234

No Fee Registration: Click Here